γ-FR Inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the activity of the γ-FR (gamma folate receptor), a protein involved in the transport and cellular uptake of folates. Folate receptors, including the γ-FR subtype, play a critical role in the cellular uptake of folate, which is essential for DNA synthesis, repair, and methylation processes. The γ-FR is a high-affinity receptor that binds to folate and its derivatives, facilitating their transport into the cell via receptor-mediated endocytosis. Inhibitors of γ-FR function by binding to the receptor, either at the folate-binding site or at regions critical for receptor conformation and function, thereby blocking the receptor's ability to bind and internalize folates. This inhibition disrupts the normal folate metabolism pathway, which can affect various cellular processes dependent on folate availability.
The chemical structure and properties of γ-FR Inhibitors are meticulously designed to ensure high specificity and efficacy in targeting the receptor. These inhibitors often mimic the structure of folate or its analogs, allowing them to competitively bind to the folate-binding site on the γ-FR. Alternatively, some inhibitors may interact with other critical sites on the receptor that are essential for its proper folding, dimerization, or interaction with other cellular components involved in the endocytic process. The molecular design typically includes hydrophobic regions that fit into the receptor's binding pocket and polar or charged functional groups that form hydrogen bonds or ionic interactions with key amino acids within the receptor. The solubility, stability, and bioavailability of these inhibitors are optimized to ensure they can effectively reach the γ-FR in its native cellular environment. Additionally, the kinetics of binding-such as the rates at which the inhibitor associates with and dissociates from the receptor-play a crucial role in determining the duration and potency of the inhibition. By understanding the interactions between γ-FR Inhibitors and the receptor, researchers can gain deeper insights into the molecular mechanisms governing folate transport and the broader implications of modulating this pathway in cellular function and metabolic processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate is a folate analogue that competitively inhibits dihydrofolate reductase, reducing cellular folate levels and potentially downregulating FRα expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Fluorouracil is an antimetabolite that interferes with DNA synthesis. Its catabolites can deplete cellular folate pools, potentially reducing FRα expression. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
Aminopterin is a folic acid antagonist that inhibits dihydrofolate reductase, leading to a decrease in cellular folate levels and potential downregulation of FRα expression. | ||||||
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid | 137281-23-3 | sc-479733 | 250 mg | $330.00 | 1 | |
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid is a multitargeted antifolate that inhibits several folate-dependent enzymes, potentially reducing FRα expression by depleting cellular folate. | ||||||
Raltitrexed | 112887-68-0 | sc-219933 | 10 mg | $143.00 | ||
Raltitrexed is a thymidylate synthase inhibitor that can cause folate depletion, potentially leading to decreased FRα expression. | ||||||
Pyrimethamine | 58-14-0 | sc-208190 sc-208190A sc-208190B | 1 g 5 g 25 g | $78.00 $233.00 $809.00 | 5 | |
Pyrimethamine is a compound that inhibits dihydrofolate reductase, possibly reducing cellular folate levels and FRα expression. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $53.00 | ||
Triamterene is a diuretic that has been shown to inhibit folate transport, potentially reducing FRα expression. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $60.00 $75.00 $125.00 $205.00 | 8 | |
Sulfasalazine is an anti-inflammatory compound that can inhibit folate transport, potentially leading to decreased FRα expression. | ||||||
Minocycline, Hydrochloride | 13614-98-7 | sc-203339 sc-203339A sc-203339B sc-203339C sc-203339D sc-203339E sc-203339F | 50 mg 250 mg 1 g 2.5 g 10 g 100 g 1 kg | $52.00 $168.00 $275.00 $622.00 $1234.00 $5722.00 $24490.00 | 36 | |
Minocycline, Hydrochloride is a compound that has been shown to downregulate FRα expression in certain cell types, although the mechanism is not fully understood. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $90.00 $251.00 | 5 | |
Zoledronic acid, anhydrous is a bisphosphonate that has been shown to downregulate FRα expression in certain cancer cells, although the exact mechanism is not clear. | ||||||